← SynDRA
saralasin
SynDRA canonical compound SYN0041773 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Primary target(s) | AGTR1 |
| Mechanism of action | angiotensin receptor antagonist |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- AGTR1
- AGTR2
- Agtr1
- Agtr1b
- Agtr2
Mechanisms of action (all sources)
- AGTR1 ANTAGONIST
- Type-1 angiotensin II receptor antagonist
- angiotensin receptor antagonist
- AGTR2 INHIBITOR
- AGTR1 INHIBITOR
- AGTR1 MODULATOR
Drug classes
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
Cross-references
Synonyms
- saralasin acetate
- saralasin acetate hydrate
- aralasin
- Saralasine
- Saralasina
- 1-sar-8-ala-angiotensin ii
- Sar-arg-val-tyr-val-his-pro-ala
- Saralasin Acetate
- Sarenin
- Saralasin acetate [USAN]
- Saralasin acetate (USAN)
- UNII-FO21Z580M4
- Sarenin (TN)
- SCHEMBL2200145
- CHEMBL1200670
- FO21Z580M4
- 34273-10-4 (Parent)
- D04126
- [Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate
- [Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate, >
- UNII-H2AFV2HE66
- (Sar1,Val5,Ala8)-Angiotensin II
- CHEMBL938
- H2AFV2HE66
- Saralasinum [INN-Latin]
- Saralasin [INN:BAN]
- Saralasine [INN-French]
- Saralasina [INN-Spanish]
- Saralasinum
- (1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II
- Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
- NCGC00166135-01
- N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine
- SCHEMBL23
- AC1O44IX
- DSSTox_RID_81710
- Sar-Arg-Val-Tyr-Val-His-Pro-Ala
Look up saralasin in the interactive SynDRA portal →